The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
J Am Chem Soc. 2021 Apr 7;143(13):5141-5149. doi: 10.1021/jacs.1c00990. Epub 2021 Mar 30.
Ligand-induced protein degradation has emerged as a compelling approach to promote the targeted elimination of proteins from cells by directing these proteins to the ubiquitin-proteasome machinery. So far, only a limited number of E3 ligases have been found to support ligand-induced protein degradation, reflecting a dearth of E3-binding compounds for proteolysis-targeting chimera (PROTAC) design. Here, we describe a functional screening strategy performed with a focused library of candidate electrophilic PROTACs to discover bifunctional compounds that degrade proteins in human cells by covalently engaging E3 ligases. Mechanistic studies revealed that the electrophilic PROTACs act through modifying specific cysteines in DCAF11, a poorly characterized E3 ligase substrate adaptor. We further show that DCAF11-directed electrophilic PROTACs can degrade multiple endogenous proteins, including FBKP12 and the androgen receptor, in human prostate cancer cells. Our findings designate DCAF11 as an E3 ligase capable of supporting ligand-induced protein degradation via electrophilic PROTACs.
配体诱导的蛋白质降解已成为一种引人注目的方法,可以通过将这些蛋白质定向到泛素蛋白酶体机制来促进细胞中蛋白质的靶向消除。到目前为止,仅发现少数 E3 连接酶能够支持配体诱导的蛋白质降解,这反映了用于蛋白水解靶向嵌合体(PROTAC)设计的 E3 结合化合物的缺乏。在这里,我们描述了一种使用候选亲电子 PROTAC 的重点文库进行的功能筛选策略,以发现通过共价结合 E3 连接酶降解人细胞中蛋白质的双功能化合物。机制研究表明,亲电子 PROTAC 通过修饰 DCAF11 中的特定半胱氨酸起作用,DCAF11 是一种 poorly characterized E3 连接酶底物衔接子。我们进一步表明,DCAF11 定向亲电子 PROTAC 可以降解人前列腺癌细胞中的多种内源性蛋白质,包括 FBKP12 和雄激素受体。我们的研究结果将 DCAF11 指定为一种 E3 连接酶,能够通过亲电子 PROTAC 支持配体诱导的蛋白质降解。